I also like the new CEO, Cheryl Maley. This deal tells me that she is hungry and connected. I expect that there will be more to come. In the past I've had good luck betting on new CEO's turning around a company that has been languishing for years. Stock trading around 14c supported by about 7c cash per share makes it a good spec. Little to no financial risk, SPL won't go broke, not with $30 million on hand. Then look at it from Medixci's point of view. They have deals coming at them everyday while they also are out beating the bushes for winners. Choosing SPL indicates a belief that among all the opportunities they have before them at that moment, this joint venture well give them the best return. This one deal won't make SPL, but it is a signal to the market that it no longer is a moribund company chasing its tail.
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-147
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.6¢ | $35.40K | 364.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 365495 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 16718 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 365495 | 0.097 |
2 | 150000 | 0.095 |
2 | 110000 | 0.094 |
2 | 300667 | 0.093 |
2 | 525600 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 16718 | 1 |
0.105 | 56878 | 2 |
0.110 | 210058 | 7 |
0.115 | 109827 | 3 |
0.120 | 59907 | 7 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |